Stephen Pendergast/LinkedIn
Apr 22, 2026, 15:22
Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
Stephen Pendergast, Consultant in Systems Engineering (Radar, Data Links, and Satellite Communications) and Senior Systems Engineer, shared a post on LinkedIn:
“Researchers at Japan’s Nara Medical University have engineered hemoglobin vesicles that work for blood transfusion replacements all blood types and last for years.
As clinical trials advance, parallel efforts in the U.S. and U.K. are converging on a long-elusive goal: a shelf-stable substitute for donated blood.
This could revolutionize emergency room and battlefield emergency care.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers